Pharmaceutical industry development program will be adopted in Kazakhstan

рус | en

Pharmaceutical industry development program will be adopted in Kazakhstan

Pharmaceutical industry development program will be adopted in Kazakhstan


As part of a working trip to the Karaganda region, Prime Minister Askar Mamin held a meeting on development of the republic's pharmaceutical industry, reports with reference to the press service of the head of the Government of the Republic of Kazakhstan.

Minister of Industry and Infrastructure Development Beibut Atamkulov, Vice Minister of Health Lyudmila Byurabekova, Chairman of the Board of SK-Pharmacia Yerkhat Iskaliev, Director of Khimpharm Aigul Isenova, Head of Super-Pharm LLP Kairat Kaimoldaev, Chairman of the Association of Manufacturers of Medical Devices Gulmira Mukhamedzhanova reported on the situation and prospects for development of the pharmaceutical industry of the Republic of Kazakhstan.

In a pandemic, following the results of 7 months of this year, the production volumes of pharmaceutical companies increased by 23.2% to 70.2 billion tenge. There are 96 enterprises in the industry, 33 of which are for medicines, 41 - for medical devices, 22 - for medical equipment. Within the framework of the Industrialization Map, 41 projects were put into operation with an investment of 62.9 billion tenge and creation of 5 thousand new jobs. “Growth points” of the Kazakhstani pharmaceutical industry are located in Almaty, Shymkent, Almaty and Karaganda regions.

"The pharmaceutical industry of Kazakhstan has great potential for development. The main task is to make a breakthrough in the domestic production of medicines and medical devices, ensuring their sufficient stocks and expanding the range. The country's population should have free access to quality medical products," Mamin said.

In order to further develop the domestic pharmaceutical industry, the Head of Government instructed the Ministry of Industry, taking into account the opinion of the business community, to develop and submit a draft Program for development of the pharmaceutical industry in September this year.

The Prime Minister stressed that optimal prices should be established on the domestic drug market, ensuring availability and quality for the population, and reasonable profitability for business. At the same time, he instructed to approve the standards for production of medical masks and other personal protective equipment.

The Ministry of Health, together with SK-Pharmacia, was instructed to revise the mechanisms for planning the availability of medicines in medical organizations, to optimize the requirements for registration of medicines, and to introduce a system for forecasting the volume of purchases for domestic manufacturers.

The Head of Government emphasized the need to ensure the accelerated entry of domestic medicines to foreign markets, to minimize barriers for registration of new medicines.

As part of the working trip, Askar Mamin visited ArcelorMittal Temirtau JSC, inspected the transport interchange of the Karaganda-Temirtau highway, and also got acquainted with the work of healthcare facilities, the enterprise for the production of immunobiological and biopharmaceuticals "Karaganda pharmaceutical complex", a plant for production of technical and of medical gases "Linde Gas Kazakhstan", a logistics complex for the maintenance and storage of medicines and medical products "Amanat".

17:30, 19 August 2020


Go Back

Leave a comment